Comparison between GNH India Pharmaceuticals IPO and HCIN Networks IPO.
GNH India Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while HCIN Networks IPO is a SME Bookbuilding proposed to list at NSE SME.
| GNH India Pharmaceuticals IPO | HCIN Networks IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Swastika Investmart Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of GNH India Pharmaceuticals IPO is up to ₹0.00 Cr whereas the issue size of the HCIN Networks IPO is up to ₹0.00 Cr. The final issue price of GNH India Pharmaceuticals IPO is and of HCIN Networks IPO is .
| GNH India Pharmaceuticals IPO | HCIN Networks IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 37,00,000 shares | 55,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 55,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
GNH India Pharmaceuticals IPO opens on , while HCIN Networks IPO opens on . The closing date of GNH India Pharmaceuticals IPO and HCIN Networks IPO is , and , respectively.
GNH India Pharmaceuticals IPO P/E ratio is , as compared to HCIN Networks IPO P/E ratio of .
| GNH India Pharmaceuticals IPO | HCIN Networks IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 76.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 22.99% | 40.07% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.49% | 25.54% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 16.81% | 35.70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the GNH India Pharmaceuticals IPO Retail Individual Investors (RII) are offered while in HCIN Networks IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in GNH India Pharmaceuticals IPO and in HCIN Networks IPO.
GNH India Pharmaceuticals IPO subscribed in total, whereas HCIN Networks IPO subscribed .
